Compare Stocks → Bible Shocker: Have You Seen Elon Musk’s Miracle? (From InvestorPlace) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:BISNASDAQ:JDOCNASDAQ:MEDXNASDAQ:ZBIO Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBISProShares UltraShort Nasdaq Biotechnology$17.59+0.9%$18.66$16.37▼$26.51$2.99M-1.4117,729 shs1,160 shsJDOCJPMorgan Healthcare Leaders ETF$57.900.0%$57.02$48.43▼$58.55$7.53M0.61510 shs7 shsMEDXHorizon Kinetics Medical ETF$28.90-0.2%$28.70$27.02▼$31.40$17.34M0.91888 shs359 shsZBIOProShares UltraPro Short Nasdaq Biotechnology$10.09$10.05$8.28▼$18.64$2.52MN/A32,378 shsN/A7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBISProShares UltraShort Nasdaq Biotechnology0.00%-4.51%-16.16%-1.29%-11.56%JDOCJPMorgan Healthcare Leaders ETF0.00%+0.94%+5.06%+1.11%+5,789,999,900.00%MEDXHorizon Kinetics Medical ETF0.00%+1.44%+5.35%-2.58%+2,890,379,900.00%ZBIOProShares UltraPro Short Nasdaq Biotechnology0.00%0.00%0.00%0.00%0.00%Bible Shocker: Have You Seen Elon Musk’s Miracle? (Ad)Breaking News: Elon Musk Invents New Type of A.I. (Shocking) Elon Musk is about to shock the world again with this new type of A.I.… Minting new millionaires in the process.Click here for the full story…MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBISProShares UltraShort Nasdaq BiotechnologyN/AN/AN/AN/AN/AN/AN/AN/AJDOCJPMorgan Healthcare Leaders ETFN/AN/AN/AN/AN/AN/AN/AN/AMEDXHorizon Kinetics Medical ETFN/AN/AN/AN/AN/AN/AN/AN/AZBIOProShares UltraPro Short Nasdaq BiotechnologyN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBISProShares UltraShort Nasdaq Biotechnology0.00N/AN/AN/AJDOCJPMorgan Healthcare Leaders ETFN/AN/A$63.219.17% UpsideMEDXHorizon Kinetics Medical ETF0.00N/A$37.7330.53% UpsideZBIOProShares UltraPro Short Nasdaq Biotechnology0.00N/AN/AN/ACurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBISProShares UltraShort Nasdaq BiotechnologyN/AN/AN/AN/AN/AN/AJDOCJPMorgan Healthcare Leaders ETFN/AN/AN/AN/AN/AN/AMEDXHorizon Kinetics Medical ETFN/AN/AN/AN/AN/AN/AZBIOProShares UltraPro Short Nasdaq BiotechnologyN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBISProShares UltraShort Nasdaq BiotechnologyN/AN/A0.00∞N/AN/AN/AN/AN/AJDOCJPMorgan Healthcare Leaders ETFN/AN/A27.37∞N/AN/AN/AN/AN/AMEDXHorizon Kinetics Medical ETFN/AN/A17.98∞N/AN/AN/AN/AN/AZBIOProShares UltraPro Short Nasdaq BiotechnologyN/AN/A0.00∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBISProShares UltraShort Nasdaq Biotechnology$0.472.67%N/AN/AN/AJDOCJPMorgan Healthcare Leaders ETF$0.080.14%N/AN/AN/AMEDXHorizon Kinetics Medical ETF$1.645.67%N/AN/AN/AZBIOProShares UltraPro Short Nasdaq Biotechnology$0.030.30%N/AN/AN/ALatest ZBIO, BIS, JDOC, and MEDX DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/19/2024BISProShares UltraShort Nasdaq Biotechnology$0.15863/20/20243/21/20243/27/2024(Data available from 1/1/2013 forward)OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBISProShares UltraShort Nasdaq BiotechnologyN/AJDOCJPMorgan Healthcare Leaders ETFN/AMEDXHorizon Kinetics Medical ETF62.18%ZBIOProShares UltraPro Short Nasdaq BiotechnologyN/AInsider OwnershipCompanyInsider OwnershipBISProShares UltraShort Nasdaq BiotechnologyN/AJDOCJPMorgan Healthcare Leaders ETFN/AMEDXHorizon Kinetics Medical ETF4.30%ZBIOProShares UltraPro Short Nasdaq BiotechnologyN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableBISProShares UltraShort Nasdaq BiotechnologyN/A170,000N/AOptionableJDOCJPMorgan Healthcare Leaders ETFN/A130,000N/AN/AMEDXHorizon Kinetics Medical ETFN/A600,000N/ANot OptionableZBIOProShares UltraPro Short Nasdaq BiotechnologyN/A250,000N/AOptionableZBIO, BIS, JDOC, and MEDX HeadlinesRecent News About These CompaniesFebruary 25, 2023 | benzinga.comBullfrog AI Hldgs Stock (NASDAQ:BFRG), Quotes and News SummaryFebruary 16, 2023 | morningstar.comProFunds Short NASDAQ-100 SvcSeptember 17, 2022 | wsj.comNasdaq Biotechnology Index NBIAugust 23, 2022 | ca.finance.yahoo.comProShares UltraPro Short Nasdaq Biotechnology (ZBIO)Media Sentiment Over TimeTop Headlines3 Stocks Leading the U.S. Agriculture ComebackApril 26, 2024 10:10 AMView 3 Stocks Leading the U.S. Agriculture ComebackHow to Use Put Debit Spreads to Profit From Falling Stocks April 26, 2024 9:30 AMView How to Use Put Debit Spreads to Profit From Falling Stocks Stock market today: Alphabet and Microsoft help Wall Street clinch its best week in nearly 6 monthsApril 26, 2024 3:21 AMView Stock market today: Alphabet and Microsoft help Wall Street clinch its best week in nearly 6 monthsSeagate Technology Warns Cloud Demand is Heating Up April 30, 2024 10:10 AMView Seagate Technology Warns Cloud Demand is Heating Up Cannabis Stocks: Game-Changing Catalyst for the Sector?May 3, 2024 7:00 AMView Cannabis Stocks: Game-Changing Catalyst for the Sector?All HeadlinesCompany DescriptionsProShares UltraShort Nasdaq BiotechnologyNASDAQ:BISProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in equity securities and derivatives that have similar daily performance characteristics as twice (200%) the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.JPMorgan Healthcare Leaders ETFNASDAQ:JDOCThe JPMorgan Healthcare Leaders ETF Healthcare Leaders ETF (JDOC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies located around the globe.The adviser seeks to provide long-term capital appreciation. JDOC was launched on Nov 1, 2023 and is issued by JPMorgan Chase.Horizon Kinetics Medical ETFNASDAQ:MEDXThe Horizon Kinetics Medical ETF (MEDX) is an exchange-traded fund that mostly invests in health care equity. The fund actively invests in global companies within the broad health care sector. Stock selection and weighting emphasizes those invested in cancer research and pharmaceutical developments. MEDX was launched on Jan 27, 2023 and is managed by Horizon Kinetics.ProShares UltraPro Short Nasdaq BiotechnologyNASDAQ:ZBIO Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.